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Objective: The introduction of ablation technology has simplified surgical intervention for atrial fibrillation.
However, most ablation devices cannot create focal transmural lesions on the beating heart and have difficulty
ablating specific regions of the atria, such as the atrioventricular isthmus, coronary sinus, and ganglionated
plexus. The purpose of this study was to examine the efficacy of a pen-type bipolar radiofrequency ablation device
on both arrested and beating hearts.
Methods: Endocardial and epicardial atrial tissues in the free wall, left atrial roof, atrioventricular annuli, and
coronary sinus were ablated for varying time intervals (2.5–15 seconds) in porcine cardioplegically arrested
(n¼ 6) and beating (n¼ 9) hearts. The hearts were stained with 1% 2,3,5-triphenyl-tetrazolium chloride solution
and sectioned to determine lesion depth and width. In 5 animals epicardial fat pads containing ganglionated
plexus were stimulated and ablated.
Results: Lesion depth increased with ablation time similarly in both arrested and beating hearts. Transmurality
was fully achieved in the thin atrial tissue (<4mm) at 10 seconds in the beating and arrested hearts. The device had
a maximal penetration depth of 6.1 mm. Epicardial ablation of the coronary sinus showed complete penetration
through the left posterior atrium only in the arrested heart. Seven of 17 fat pads demonstrated a vagal response. All
vagal responses were eliminated after ablation.
Conclusion: The bipolar pen effectively ablated atrial tissue in both arrested and beating hearts. This device
might allow the surgeon to ablate tissue in regions not accessible to other devices during atrial fibrillation surgery.E
TThe introduction of alternative energy sources for creating
atrial lesions has made atrial fibrillation (AF) surgery more
accessible to surgeons by reducing the difficulty and length
of these procedures.1-4 One of these new technologies, bipo-
lar radiofrequency (RF) ablation, has been shown by our lab-
oratory and others to reliably create continuous transmural
linear lesions on both the arrested and the beating heart.5-7
These devices require the surgeon to clamp the atrial tissue
between 2 jaws with embedded electrodes. These devices,
although effective, have significant shortcomings.
First of all, they are unable to ablate up to the tricuspid and
mitral valve annuli because of the thickness of the atrioven-
tricular groove. There are also concerns about ablating
directly on the coronary arteries or valve tissue.
Second, it is not possible to create small focal lesions be-
cause of the length of the electrodes. As an example, recent
data have suggested that there might be a benefit from focal
From the Division of Cardiothoracic Surgery, Washington University School of
Medicine, Barnes–Jewish Hospital, St. Louis, Mo.
Supported in part by National Institutes of Health grants RO-1HL032257-21 and F32
HL082129-02; and a grant from AtriCure Inc, West Chester, OH. Richard Schuess-
ler and Ralph Damiano report consulting fees and grant support from Atricure.
Received for publication Jan 24, 2008; revisions received March 18, 2008; accepted
for publication April 3, 2008.
Address for reprints: Ralph J. Damiano, Jr, MD, Department of Cardiac Surgery,
Washington University School of Medicine, Barnes–Jewish Hospital, 3108 Queeny
Tower, One Barnes–Jewish Hospital Plaza, St. Louis, MO 63110 (E-mail:
damianor@wustl.edu).
J Thorac Cardiovasc Surg 2008;136:1295-301
0022-5223/$34.00
Copyright  2008 by The American Association for Thoracic Surgery
doi:10.1016/j.jtcvs.2008.04.030The Journal of Thoracic and Cablation of fat pads or atrial tissue containing ganglionated
plexi (GPs) and fibers thought to be responsible for the ini-
tiation of AF.8 Unfortunately, most of the presently available
unipolar technology (ie, RF energy, microwave, and cryoa-
blation) has been unable to reliably create transmural lesions
on the beating heart.9-12 It would be necessary to develop
a new device that can be used for epicardial ablation on
the beating heart and for ablating tissue in regions not acces-
sible to other devices during AF surgery to overcome these
shortcomings. A novel bipolar pen (Isolator Transpolar Pen;
AtriCure, Inc, West Chester, Ohio) was developed to create
these ablations on both arrested and beating hearts.
The purpose of this study was to test the performance of
a bipolar probe that can apply RF energy on both arrested
and beating hearts. The ability of this device to create trans-
mural lesions up to the mitral and tricuspid annuli, over the
coronary sinus, and on the atrial free wall was evaluated in
an acute porcine model. In addition, the GP fat pad was stim-
ulated and ablated to test the efficacy of the pen device to
ablate GPs.
MATERIALS AND METHODS
Ablation Device
Lesions were created with the Isolator Transpolar Pen (AtriCure, Inc;
Figure 1). The device consists of a handheld probe with a 5-mm-wide tip,
an integral cable passing through a flexible shaft, and a reusable ablation
and sensing unit. Two 1-mm-wide, 8-mm-long electrodes separated by 3
mm of insulation are located on the tip of the pen. RF energy is driven be-
tween the 2 electrodes. During energy delivery, the ablation and sensing unit
adjusts energy delivery by determining online measurements of tissueardiovascular Surgery c Volume 136, Number 5 1295
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TAbbreviations and Acronyms
AF ¼ atrial fibrillation
GP ¼ ganglionated plexus
RF ¼ radiofrequency
conductance every 20 ms during ablation. The power delivered varies de-
pending on the measured conductance at each time point. Conductance
was calculated frommeasurements of current and voltage. The pen operated
at a maximum power setting of 15 W, and to minimize tissue damage, such
as charring and perforation, the power tapered down as tissue impedance
increased beyond 400 U.
Experimental Protocol
Fifteen domestic pigs weighing 70 to 80 kg were used in this study. All
animals received humane care in compliance with the ‘‘Guide for the care
and use of laboratory animals’’ published by the National Institutes of
Health (publication no. 85-23, revised). Each animal was premedicated
with intramuscular ketamine, intubated, and anesthetized with 2% to 4%
isoflurane. Heart rate, blood pressure, and oxygen saturation were moni-
tored continuously throughout the procedure. The heart was exposed
through a median sternotomy. In 6 animals (group A, arrested heart) a cardi-
oplegia cannula was placed in the proximal ascending aorta. After systemic
heparinization (100 U/kg), the superior vena cava and inferior vena cava
were snared with umbilical tapes, and the aorta was crossclamped. A cardi-
oplegic solution (Plegisol; Abbott Laboratories, North Chicago Ill) was in-
fused at a volume of 10 mg/kg into the aortic root at a pressure of 70 to 80
mm Hg. A myocardial temperature probe was placed into the interventric-
ular septum, and a normal saline slush solution was placed topically on
the heart to maintain myocardial temperature between 10C and 15C. Car-
dioplegia solution was infused every 20 minutes to maintain cardiac arrest.
After the atriotomy, timed endocardial stamping lesions were created on the
right and left atrial free walls for durations of 2.5, 5, 7.5, 10, 12.5, and 15
seconds and up to the posterior mitral annulus and the anterior tricuspid an-
nulus for durations of 5, 10, and 15 seconds. Timed epicardial stamping le-
sions were created on the coronary sinus for ablation durations of 5, 10, and
15 seconds.
In 9 animals (group B, beating heart) epicardial stamping lesions were
created on the right and left atrial free walls and coronary sinus on the beat-
ing normothermic heart without cardiopulmonary bypass. Timed atrial
ablations were performed for durations of 2.5, 5, 7.5, 10, 12.5, and 151296 The Journal of Thoracic and Cardiovascular Suseconds on the atrial free wall, and coronary sinus ablations were performed
for durations of 5, 10, and 15 seconds. Timed atrial ablations were per-
formed for durations of 7.5, 10, 12.5, and 15 seconds on the left atrial
roof. The ablation times at each atrial site were randomized so as to avoid
any confounding influence of changes in atrial wall thickness at each site.
In 5 animals the tip of the pen device was placed on the 4 anatomic GP
fat pads (interatrial septal, dorsal atrial, ventral right atrial, and left superior
vena cava–left atrial fat pad)13 to deliver high-frequency stimulation at a rate
of 1000 pulses/min with a pulse duration of 0.1 to 1.5 ms and voltage of ap-
proximately 1 to 6 V (PACE 203H; Oscar, Inc, Denver, Colo). During high-
frequency stimulation, the electrocardiogram was monitored to detect R-R
prolongation. R-R prolongation by 10% or atrioventricular block was
defined as a positive vagal reflex caused by GP stimulation. GP fat pads
were ablated for 5, 10, and 15 seconds, respectively, in each animal.
High-frequency stimulation was repeated only on the GP fat pads that
had demonstrated a vagal reflex before the ablation.
Histologic Assessment
At the end of the procedure, the animals were killed, and the hearts were
removed en bloc. The atrial ablation lesions were examined for evidence of
charring and tissue disruption. The heart was placed in a 1% 2,3,5-tri-
phenyl-tetrazolium chloride solution and incubated at room temperature
for 45 minutes. Each lesion was sectioned at the midportion, perpendicular
to the long axis of the ablation. Each section was photographed digitally
next to a 5-mm caliper. Lesion width and depth and myocardial tissue thick-
ness were analyzed with commercial software (Adobe Photoshop, San Jose,
FIGURE 1. Isolator Transpolar Pen (AtriCure, Inc).TABLE 1. Atrial lesion sets in groups A and B
Ablation width (mm) Ablation depth (mm) Tissue thickness (mm)
Ablation time (s) Group A Group B Group A Group B Group A Group B
2.5 2.5  0.9 4.3  2.3 1.1  0.7 1.6  1.0 2.9  1.4 3.4  2.0
(1.2–3.7) (0.5–10.2) (0.5–2.2) (0.2–5.0) (1.2–4.7) (0.7–5.4)
5.0 3.5  1.1 6.2  2.2* 2.2  0.9* 2.1  1.1 3.0  1.0 2.8  1.3
(1.9–5.8) (2.9–10.7) (0.6–3.8) (0.9–4.3) (1.2– 4.6) (0.9–4.9)
7.5 4.1  1.5 7.0  2.4 2.6  1.1 2.3  0.9* 3.0  1.4 2.9  1.0
(2.0–7.5) (4.1–13.2) (0.9–4.4) (1.2–5.1) (0.9–4.8) (1.2–5.1)
10.0 4.9  1.3* 7.5  3.1 2.6  0.9 2.7  1.0 2.6  0.9 3.7  2.3
(2.3–7.4) (3.7–13.7) (1.4–4.7) (1.1–4.9) (1.4–4.7) (1.1–8.6)
12.5 4.9  1.4 7.4  2.7 2.2  0.8 3.0  1.1z 2.5  1.2 3.4  1.7
(2.2–7.0) (2.7–14.0) (0.8–3.3) (1.5–5.5) (0.8–5.2) (1.5–9.4)
15.0 5.7  1.4y 7.6  2.6 3.1  0.9x 3.1  1.4 3.1  0.9 3.1  1.4
(2.6–7.7) (3.8–13.2) (1.3–5.3) (1.1–6.1) (1.3–5.3) (1.1–6.1)
Data are presented as mean values standard deviation (range).Group A, Arrested heart; group B, beating heart. *P<.05 versus 2.5-second lesion. yP<.05 versus 5-second lesion.
zP< .05 versus 7.5-second lesion. xP< .05 versus 12.5-second lesion.rgery c November 2008
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from the unstained area to the pink halo region surrounding each lesion.
The accuracy of this technique was  0.03 mm. Coronary sinus and epicar-
dial fat pad lesions were sectioned and analyzed in the same manner as the
atrial tissue. Each lesion was examined to determine the depth of penetra-
tion. Transmural lesions across the coronary sinus were defined as lesions
that penetrated both the anterior and posterior walls that were adjacent to
the left atrial tissue.
Statistical Analysis
Data were expressed as means  standard deviation. One-way analysis
of variance was used to compare the lesion data in each ablation time.
The quantitative difference between groups A and Bwas analyzed bymeans
of 2-way analysis of variance. All statistical procedures were performed
with the SPSS 11.5 statistical package (SPSS, Inc, Chicago, Ill).
RESULTS
On gross inspection, all lesions were pale and easily vis-
ible. Tissue disruption or charring was not observed in any
lesion. On the arrested heart, there was no evidence of collat-
eral damage with endocardial ablation with the pen device.
Particularly, no lesion reached the parietal pericardium.
FIGURE 2. Percentage transmural lesions versus ablation time in the atrial
lesions in groups A (arrested heart) and B (beating heart).The Journal of Thoracic and CAtrial lesion depth was compared with atrial wall thickness
in the area of ablation, and the number of transmural lesions
was determined.
Atrial Lesions
In group A a total of 12 lesions were created for each ab-
lation time on the endocardium of the right and left atrial free
walls. In group B, on the beating heart, a total of 19  1.4
lesions (range, 18–21 lesions) were created for each ablation
time on the epicardium of the atrial free wall and the left
atrial roof. The 2.5-second timed lesion had the smallest
width and depth among any of the timed lesions in both
groups (Table 1). Ablation depth increased in a time-depen-
dent manner. Ablation width in each lesion was significantly
greater in group B than in group A. On the other hand, there
was no significant difference in ablation depth and tissue
thickness between the 2 groups. The greatest lesion depths
(5.3 mm in group A and 6.1 mm in group B) were observed
after the 15-second ablation.
Ablation times of more than 10 seconds achieved trans-
murality in all lesions in group A, except in one instance
(12.5-second ablation), when the tissue thickness was 5.2
mm (35/36 [97%] ablations). In group B the percentage of
transmurality was comparatively low at ablation times of
more than 10 seconds (53/63 [84%] ablations). Only a 15-
second ablation guaranteed a transmural lesion (Figure 2).
There were no transmural lesions when the tissue thick-
ness was more than 6.7 mm (Figure 3). However, transmur-
ality was fully achieved in thin atrial tissue (4 mm) at 10
seconds in both groups A and B.
Mitral and Tricuspid Annulus Lesions on the
Arrested Heart
In group A a total of 12 lesions for each ablation time were
created on the endocardium up to both the mitral and tricuspid
annuli. The mean atrial tissue thickness was 2.2  1.1 mm
(range, 0.8–4.0 mm). Ablation width and depth in theE
TFIGURE 3. Relationship between ablation depth versus tissue thickness in groups A and B.ardiovascular Surgery c Volume 136, Number 5 1297
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T5-second lesions were significantly less than those in the 15-
second lesions (Table 2). The percentage of transmural lesions
up to the mitral and tricuspid annuli demonstrated that all le-
sions at ablation times ofmore than 10 seconds were transmu-
ral (24/24 ablations). There was no visible injury to the area
surrounding the coronary arteries. Figure 4,A, shows a 15-sec-
ond timed lesion up to the tricuspid annulus, which ablated the
epicardial fatty tissue but did not reach the right coronary ar-
tery wall. With ablation up to the mitral annulus, the lesion
reached the inferoposterior wall of the coronary sinus in 2
cases of 15-second ablations (Figure 4, B).
Coronary Sinus Lesions on the Arrested and Beating
Hearts
In both groups 50% of 5-second ablations through the
coronary sinus were not transmural. In contrast, lesions
were transmural in all 10- and 15-second ablations. In group
A lesions also penetrated down to the left atrium in 16% of
10-second and 50% of 15-second ablations (Figure 5).
Epicardial GP Fat Pad Ablation
Seventeen GP fat pads were visually identified in this
study. Seven (41%) fat pads (1 interatrial septal fat pad, 4
dorsal atrial fat pads, and 2 ventral fat pads) showed R-R
prolongation during high-frequency stimulation (Figure 6,
A). The vagal response was eliminated in all 7 fat pads after
timed ablation. Lesions were created above all 17 fat pads,
regardless of the vagal reflex. The pen could not penetrate
the atrial tissue beneath the fat pad, except for one lesion
in each of the 10- and 15-second ablations (Figure 6, B).
DISCUSSION
The introduction of ablation devices has revolutionized
surgical intervention for AF. However, unipolar energy
sources have not been capable of reliably creating transmu-
ral lesions on the beating heart.9-12 Epicardial fat, intramyo-
cardial blood flow, and the presence of blood cooling the
endocardial surface are assumed to be responsible for limit-
ing the depth of penetration. Bipolar RF energy was devel-
TABLE 2. Endocardial lesion sets up to the mitral and tricuspid
annuli
Ablation
time (s)
Ablation
width
(mm)
Ablation
depth
(mm)
Tissue
thickness
(mm)
Transmurality
(%)
5.0 3.8  1.2 1.6  0.3 1.7  0.4 83 (10/12)
(2.1–5.3) (0.9–2.0) (1.3–2.9)
10.0 5.9  1.0* 2.0  0.9 2.0  0.9 100 (12/12)
(4.2–6.8) (0.8–3.6) (0.8–3.6)
15.0 6.4  1.2 2.3  0.7* 2.3  0.7* 100 (12/12)
(4.7–8.5) (1.4–4.0) (1.4–4.0)
Data are presented as mean values  standard deviation. *P< .05 versus 5-second
lesion.1298 The Journal of Thoracic and Cardiovascular Suoped to overcome this problem. These clamp devices have
been shown to effectively create transmural lesions on
both beating and arrested hearts. However, they have their
own shortcomings and cannot ablate tissue near the tricuspid
and mitral annuli or create spot lesions.
The Isolator Transpolar Pen is a handheld RF ablation de-
vice with a flexible shaft and a small tip. It has the potential
advantage of a unique bipolar configuration and an energy
output regulated by a tissue impedance algorithm. This con-
trols energy delivery and limits charring at the tissue–elec-
trode interface. It is recommended that the device be used,
as in this study, with a stamping technique to maximize its
effectiveness. If used correctly, it might be able to overcome
the above-mentioned limitations of traditional devices.
FIGURE 4. A, Example of a lesion near the tricuspid annulus. The asterisk
indicates the ablation site on the endocardial surface. The ablation pene-
trates through the atrial tissue in the tricuspid annulus and reaches the epi-
cardial fat tissue. B, Example of a lesion near the mitral annulus. The
ablation penetrates through not only atrial tissue but also through the poste-
rior wall of the coronary sinus. RCA, Right coronary artery; RV, right ven-
tricle; TV, tricuspid valve; CS, coronary sinus; LV, left ventricle;MV, mitral
valve.rgery c November 2008
Sakamoto et al Evolving TechnologyFIGURE 5. Transmural lesion across both the coronary sinus and left atrial tissue after a 15-second ablation. The asterisk indicates the ablation surface of the
coronary sinus. CS, Coronary sinus; LA, left atrium.E
TThe most important finding of this study was that lesion
depth and percentage of transmurality increased with abla-
tion time in a similar fashion on both arrested and beating
hearts. These similar dose-response relationships are differ-
ent from those seen by our laboratory and others using uni-
polar RF and other microwave energy sources, which have
significantly worse penetration on the beating heart when
compared with that seen on the arrested heart.9-12
For this device, 80% of ablations on the arrested heart and
67% of ablations on the beating heart were transmural. The
deepest penetration of the device was 6.1 mm. For tissue
thickness of 4 mm or less, all lesions were transmural at ab-
lation times of 10 seconds and greater. For tissue thickness
of 4 mm or greater, 50% of lesions at ablation times of 10
seconds or greater were transmural. According to previous
anatomic studies, the thickness of the normal human atrium
is different from site to site.14,15 Trabeculated areas and theThe Journal of Thoracic and Ccrista terminalis in the right atrium show prominent wall
thickness of greater than 6 mm. In the left atrium the atrial
roof between the right and left pulmonary veins is compar-
atively thicker than other parts of the left atrium. In the pres-
ent study tissues in these regions were remarkably thick (>8
mm) and were not transmurally ablated on the beating heart.
Based on these data, epicardial ablation on the beating heart
should be limited to the regions of atrial tissue with a thick-
ness of 4 mm or less.
Another significant finding in the present study was that
ablation width was wider on the beating heart when com-
pared with that on the arrested heart. Lower myocardial tem-
perature caused by topical cooling might have caused
diminished lateral energy delivery on the arrested heart.
In the Cox maze III procedure, cryoablation was used to
ablate the atrial tissue near the mitral and tricuspid annuli.16
Cryoablation is a reliable and safe technology that has beenFIGURE 6. A, Electrocardiographic recording during high-frequency stimulation before and after ablation. Continuous high-frequency stimulation was ap-
plied to the ventral ganglion plexus fat pad and induced R-R slowing (upper panel). After a 10-second ablation, high-frequency stimulation at the same voltage
failed to induce R-R slowing. Asterisks indicate the start of high-frequency stimulation. Arrows indicate its duration. B, The depth of penetration is shown in
the upper cartoon. The asterisk indicates the epicardial surface. The ablation did not fully penetrate the underlying atrial myocardium.ardiovascular Surgery c Volume 136, Number 5 1299
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Tused for decades in the treatment of arrhythmias. However,
creating transmural lesions takes 2 to 3 minutes. In our lab-
oratory, although the bipolar RF clamp has been shown to
create transmural lesions reliably and can replace most of
the incisions of the Coxmaze III procedure,17,18 it cannot ab-
late up to the mitral and tricuspid annuli because of the thick-
ness of the atrioventricular groove tissue and the difficult
dissection, particularly on the right atrium, required to avoid
injury to the coronary arteries. Consequently, many sur-
geons have awaited the development of a new device capa-
ble of interrupting atrial isthmus tissue safely and rapidly.
The Cardioblate pen (Medtronic, Minneapolis, Minn) is an
irrigated unipolar RF ablation device that allows production
of spot lesions and has been used for this purpose.19 It has
a unipolar electrode and results in laterally oriented heating
distribution. However, there are no experimental reports
documenting time needed for ablation. A recent clinical
study has shown that this device does not reliably create
transmural lesions, particularly at the left atrial isthmus.20
On the other hand, the Isolator Transpolar Pen was partic-
ularly effective at creating lesions in the left and right atrial
tissue near the valve annuli. This is an area of the atrium with
relatively thin tissue, usually measuring 1 to 3 mm in human
subjects.21,22 At both 10- and 15-second ablation times, all
lesions were transmural in this area.
Surgical ablation of the coronary sinus is an important
part of surgical intervention for AF. The coronary sinus is
covered with a continuous cuff of striated muscle extending
from the right atrium, and there also are muscular connec-
tions with the left atrium. Therefore activation can conduct
along the coronary sinus during AF.23,24 Omission of the
coronary sinus lesion has resulted in postoperative atrial flut-
ter after a traditional Cox maze procedure in our experience.
In the present study every 10- and 15-second ablation per-
formed with the pen device created a transmural ablation
of the coronary sinus. However, the pen could not penetrate
left atrial tissue under the coronary sinus on the beating
heart. Thus performing an epicardial ablation of the left atrial
isthmus was possible only on the arrested heart.
Focal ablation of the GP has been proposed for the treat-
ment of AF. Recent studies have shown that pulmonary vein
isolation combined with GP ablation reduced the recurrence
of AF.25 In another study selective GP ablation was used to
treat paroxysmal AF without pulmonary isolation.26 The
epicardial GP contains efferent parasympathetic, sympa-
thetic, and afferent neurons, but a vagal response is most of-
ten observed during GP stimulation. This increased vagal
tone in the atrium can play an important role in initiating
and maintaining AF.27,28
In the present study the vagal reflex could be eliminated
by ablation of the fat pad. Our data suggested that ablation
of only the epicardial tissue was able to interrupt vagal
GP. However, efferent vagal fibers are located not only epi-
cardially but also intramyocardially or subendocardially. In1300 The Journal of Thoracic and Cardiovascular Sua histologic study in the pig, the innervation patterns of epi-
cardium and endocardium were different in the atrium, sug-
gesting that the epicardial GP might be an independent
intrinsic nervous system that mediates local reflexes.29
As documented in other studies of RF energy,12,30 there
was difficulty in penetrating through adipose tissue. The
low electrical and thermal conductivity properties of fat tis-
sue are the most likely reason. The pen also might have ta-
pered power delivery with its self-limiting feature after
target tissue impedance reached 400 U at a lower power.
These findings might limit the use of this device in regions
of epicardial fat.
LIMITATIONS
One limitation of this study was the use of an acute model.
However, previous work from our laboratory has revealed
that acute and chronic histologic results have been identical
with RF technology.17,18 Second, these animals had normal
atria. In patients with mitral valve disease, the atrial myocar-
dium might be thickened and might yield different results,
and the device might not perform as well. This will require
clinical correlation. However, this study would suggest
that 15-second ablations are needed to ensure transmurality
in atrial myocardium on both the beating and the arrested
heart.
CONCLUSION
The bipolar pen effectively created transmural lesions on
atrial tissue in a time-dependent manner on both beating and
arrested hearts. Although the device did not reliably pene-
trate thick atrial tissue, it was capable of consistently creat-
ing transmural lesions near the AV annuli and coronary
sinus musculature. This device might allow the surgeon to
ablate tissue in regions not accessible to other technologies
during AF surgery.
References
1. Damiano RJ Jr. Alternative energy sources for atrial ablation: judging the new
technology. Ann Thorac Surg. 2003;75:329-30.
2. Doll N, Kiaii BB, Fabricius AM, Kornherr P, Krakor R, Gummert JF, et al. Intra-
operative left atrial ablation for atrial fibrillation using a new argon cryocatheter:
early clinical experience. Ann Thorac Surg. 2003;76:1711-5.
3. Knaut M, Spitzer SG, Karolyi L, Ebert HH, Richter P, Tugtekin SM, et al. Intra-
operative microwave ablation for curative treatment of atrial fibrillation in open
heart surgery: the MICRO-STAF and MICRO-PASS pilot trial. J Thorac Cardi-
ovasc Surg. 1999;47(suppl):379-84.
4. Ninet J, Roques X, Seitelberger R, Deville C, Pomar JL, Robin J, et al. Surgical
ablation of atrial fibrillation with off-pump, epicardial, high-intensity focused ul-
trasound: results of amulticenter trial. J ThoracCardiovasc Surg. 2005;130:803-9.
5. Gynor SL, Diodato MD, Prasad SM, Ishii Y, Schuessler RB, Bailey MS, et al. A
prospective, single-center clinical trial of a modified Cox maze procedure with
bipolar radiofrequency ablation. J Thorac Cardiovasc Surg. 2004;128:535-42.
6. Damiano RJ Jr, Gaynor SL. Atrial fibrillation ablation during mitral valve surgery
using the Atricure device. Operative Techniques Thorac Cardiovasc Surg. 2004;
9:24-33.
7. Bennussi S, Nasimbene S, Calori G, Denti P, Ziskind Z, Kassem S, et al. Surgical
ablation of atrial fibrillation with a novel bipolar radiofrequency device. J Thorac
Cardiovasc Surg. 2005;130:491-7.rgery c November 2008
Sakamoto et al Evolving Technology8. Scherlag BJ, Nakagawa H, Jackman WM, Yamanashi WS, Patterson E, Po S,
et al. Electrical stimulation to identify neural elements on the heart: their role in
atrial fibrillation. J Interv Card Electrophysiol. 2005;13:37-42.
9. Thomas SP, Guy DJ, Boyd AC, Eipper VE, Ross DL, Chard RB. Comparison of
epicardial and endocardial linear ablation using handheld probes. Ann Thorac
Surg. 2003;24:481-6.
10. Bugge E, Nicholson LA, Thomas SP. Comparison of bipolar and unipolar radio-
frequency ablation in an in vivo experimental model. Eur J Cardiothorac Surg.
2005;28:76-82.
11. Gaynor SL, Byrd GD, Diodato MD, Ishii Y, Lee AM, Prasad SM, et al. Micro-
wave ablation for atrial fibrillation: dose-response curves in the cardioplegia-ar-
rested and beating heart. Ann Thorac Surg. 2006;81:72-7.
12. Doll N, Kornherr P, Aupperle H, Fabricius AM, Kiaii B, Ullmann C, et al. Epicar-
dial treatment of atrial fibrillation using cryoablation in an acute off-pump sheep
model. Thorac Cardiovasc Surg. 2003;51:267-73.
13. Aora RC, Waldmann M, Hopkins DA, Armour JA. Porcine intrinsic cardiac gan-
glia. Anat Rec A Discov Mol Cell Evol Biol. 2003;271:249-58.
14. Ho SY, Sanchez-Quintana D, Cabrera JA, Anderson RH. Anatomy of the left
atrium: implication for radiofrequency ablation of atrial fibrillation. J Cardiovasc
Electrophysiol. 1999;10:1525-33.
15. Sanchez-Quintana D, Anderson RH, Cabrera JA, Climent V, Martin R, Farre J,
et al. The terminal crest: morphological features relevant to electrophysiology.
Heart. 2002;88:406-11.
16. Cox JL, Schuessler RB, D’Agostino HJ, Stone CM, Chang BC, Cain ME, et al.
The surgical treatment of atrial fibrillation. III. Development of a definitive surgi-
cal procedure. J Thorac Cardiovasc Surg. 1991;101:569-83.
17. Prasad SM,Maniar HS, Moustakidis P, Schuessler RB, Damiano RJ Jr. Epicardial
ablation on the beating heart: progress towards an off-pump maze procedure.
Heart Surg Forum. 2002;5:100-4.
18. Prasad SM, Maniar HS, Schuessler RB, Damiano RJ Jr. Chronic transmural atrial
ablation by using bipolar radiofrequency energy on the beating heart. J Thorac
Cardiovasc Surg. 2002;124:708-13.
19. Akpinar B, Guden M, Sagbas E, Sanisoglu I, Caynak B, Bayramoglu Z. Robotic-
enhanced totally endoscopic mitral valve repair and ablative therapy. Ann Thorac
Surg. 2006;81:1095-8.The Journal of Thoracic and C20. Deneke T, Khargi K, Muller KM, Lemke B, Mugge A, Laczkovics A, et al.
Histopathology of intraoperatively induced linear radiofrequency ablation
lesions in patients with chronic atrial fibrillation. Eur Heart J. 2005;26:
1797-803.
21. Sanchez-Quintana D, Cabrena JA, Climent V, Farre J, Mendonca MC, Ho SY.
Anatomic relations between the esophagus and left atrium and relevance for abla-
tion of atrial fibrillation. Circulation. 2005;112:1400-5.
22. Becker AE. Left atrial isthmus: anatomic aspects relevant for linear catheter abla-
tion procedures in humans. J Cardiovasc Electrophysiol. 2004;15:809-12.
23. Chauvin M, Shah DC, Haissaguerre M, Marcellin L, Brenchenmacher C. The an-
atomic basis of connections between the coronary sinus musculature and the left
atrium in humans. Circulation. 2000;101:647-52.
24. Carlson J, Santos S, Platonov PG, Rasmussen OK, Johansson R, Olsson SB. Left
atrial conduction along the coronary sinus during ectopic atrial tachycardia and
atrial fibrillation: a study using correlation function analysis. J Cardiovasc Elec-
trophysiol. 2003;14:148-53.
25. Pappone C, Santinelli V, Manguso F, Vicedomini G, Gugliotta F, Augello G, et al.
Pulmonary vein denervation enhances long-term benefit after circumferential
ablation for paroxysmal atrial fibrillation. Circulation. 2004;109:327-34.
26. Scanavacca M, Pisani CF, Hachul D, Lara S, Hardy C, Darrieux F, et al. Selective
atrial vagal denervation guided by evoked vagal reflex to treat patients with par-
oxysmal atrial fibrillation. Circulation. 2006;29:876-85.
27. Schuessler RB, Grayson TM, Bromberg BI, Cox JL, Boineau JP. Cholinergically
mediated tachyarrhythmias induced by a single extrastimulus in the isolated
canine right atrium. Circ Res. 1992;71:1254-67.
28. Liu L, Nattel S. Differing sympathetic and vagal effects on atrial fibrillation in
dogs: role of refractoriness heterogeneity. Am J Physiol Heart Circ Physiol.
1997;273:H805-16.
29. Crick SJ, Anderson RH, Ho SY, Sheppard MN. Localization and quantitation of
autonomic innervation in the porcine heart II: endocardium, myocardium and
epicardium. J Anat. 1999;195(Part 3):359-73.
30. d’Avila A, Houghtaling BS, Gutierrez P, Vragovic O, Ruskin JN,
Josephson ME, et al. Catheter ablation of ventricular epicardial tissue: a compar-
ison of standard and cooled-top radiofrequency energy. Circulation. 2004;109:
2363-9.ardiovascular Surgery c Volume 136, Number 5 1301
E
T
